1. GBp

    3,928

    Today's change

    -31.50 / -0.80%

    1 year change

    -11.88%

    As of Apr 29 2016 17:54 BST. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. Fast FT

    April 29, 2016

    Medivation rejects Sanofi's $9.3bn takeover offer

    Medivation has rejected an unsolicited $9.3bn takeover proposal from Sanofi of France as analysts predicted that...

  2. April 29, 2016

    AstraZeneca cuts costs for shift to cancer drugs

    AstraZeneca has launched a $1.1bn cost-cutting plan to accelerate its shift from mass-market primary care products to a...

Special Reports

  1. FT Health: Devices and Diagnostics

    Digital technology is unleashing a wave of medical devices to aid in the rapid detecti...
  2. Disruption & Technology

    Just as digital technology has disrupted business, Jeremy Corbyn and his far-left supp...
Search more Special Reports on this topic.

  1. Fast FT

    April 29, 2016

    AstraZeneca's revenues rise but profit hit by higher R&D

    AstraZeneca managed to increase revenues slightly in the first quarter but reported a drop in profits as it steps up...

  2. April 26, 2016

    AstraZeneca slips on downgrade worries

    AstraZeneca led the blue-chip fallers on Tuesday as a licensing deal stoked concerns that earnings due this week may...

  3. Fast FT

    April 26, 2016

    AstraZeneca sells US rights to gout treatment for up to $265m

    UK drugmaker AstraZeneca is selling the US rights to its gout treatment Zurampic. Massachusetts-based Ironwood...

  4. Fast FT

    April 26, 2016

    Opening Quote: Whitbread gets a boost from Premier Inn

    Whitbread is getting a profit boost from Premier Inn, BP’s profits are down 80 per cent, Luxembourg is where you’ll...

  5. FT Alphaville

    April 26, 2016

    FT Opening Quote

    Whitbread is getting a profit boost from Premier Inn, BP’s profits are down 80 per cent, Luxembourg is where you’ll...

  6. April 25, 2016

    Drug prices: Tweaking the formula

    What is the value of a human life? It is one of the most fraught questions in public policy as governments around the...

  7. Fast FT

    April 25, 2016

    Opening Quote: BHS blues, Rexam and Snoozebox

    BHS is sliding into administration, Rexam‘s takeover is almost in the can, Snoozebox‘s CEO has quit. FT Opening Quote,...

  8. April 22, 2016

    AstraZeneca links with three partners to focus on genomics

    AstraZeneca is to focus its drug research and development more closely on genomics — the relationship between DNA and...

  9. April 19, 2016

    The secret of a world-class biotech sector

    Britain, it is often said, has world-class science but too few world-class science-based companies. Nowhere is this...

  10. April 6, 2016

    US Treasury shatters Pfizer chief Ian Read’s merger dreams

    Ian Read cannot be faulted for his persistence. For more than two years the chief executive of Pfizer has been...

  11. April 6, 2016

    Pfizer merger collapse is serious failure of management

    Anyone who cares about decent management, long-term corporate commitment and the reputation of business will take grim...

  12. April 6, 2016

    Pfizer: plan C

    The problem is growth, and has been ever since Lipitor, the biggest-selling drug in history, lost patent protection...

  13. Fast FT

    March 30, 2016

    Medivation hires bankers to defend against takeover

    Medivation has hired bankers to defend itself from a potential takeover bid, after the US drugmaker was approached by a...

  14. Fast FT

    March 29, 2016

    Opening Quote: BoE to publish stress test scenarios

    The PRA is concerned about buy-to-let lending standards, the Bank of England will publish new stress test scenarios, AG...

  15. FT Alphaville

    March 29, 2016

    FT Opening Quote

    The PRA is concerned about buy-to-let lending standards, the Bank of England will publish new stress test scenarios, AG...

  16. Fast FT

    March 29, 2016

    British drugmakers receive drug approvals in Japan

    UK pharmaceuticals giants AstraZeneca and GlaxoSmithKline have both received some good news from Japanese regulators...

  17. Fast FT

    March 29, 2016

    Sanofi poaches immunology expert from AstraZeneca

    French drugmaker Sanofi has poached the head of research at AstraZeneca’s biologics research and development arm,...

  18. March 29, 2016

    Chi-Med taps Nasdaq for $100m to help break innovation drought

    A $100m Nasdaq flotation has given a fresh impetus to efforts by Hutchison China MediTech to produce the first drug to...

  19. March 23, 2016

    AstraZeneca heart drug hopes hit by clinical trial failure

    AstraZeneca has been dealt a setback with the failure of a clinical trial which it had hoped would boost prospects for...

  20. Fast FT

    March 23, 2016

    Opening Quote: Candour from Sports Direct; Cheltenham rumbles bookies

    Sports Direct’s Mike Ashley may have been a little too direct with the media, William Hill is licking its wounds after...

  21. Fast FT

    March 23, 2016

    AstraZeneca's latest trial for Brilinta drug ends in disappointment

    Probably not the outcome UK drugmaker AstraZeneca was hoping for. In a trial comparing the efficacy of its heart drug,...

  22. Fast FT

    March 18, 2016

    BT recruits former BG Group finance director Simon Lowth

    From BG to BT. Simon Lowth, who was finance director of BG Group until its £35bn takeover by Royal Dutch Shell, has...

  23. March 16, 2016

    Pharma merger to create UK champion in respiratory medicines

    A former senior executive at AstraZeneca is aiming to create a new UK champion in respiratory medicines after a £441m...

  24. Fast FT

    March 16, 2016

    Vectura and Skyepharma agree £441m merger

    Vectura and Skyepharma have agreed a £441m merger to create a more powerful mid-sized UK pharmaceuticals group focused...

  25. March 13, 2016

    WPP chief’s £60m pay set to spark anger

    Sir Martin Sorrell will this week receive more than £60m in one of the biggest pay cheques ever received by a FTSE 100...

  26. February 29, 2016

    AstraZeneca agrees licensing deal for Plendil in China

    AstraZeneca has struck a $500m deal to sell the marketing rights for two heart drugs, in the latest example of the UK...

  27. February 7, 2016

    AstraZeneca cancer drug presents breakthrough

    Early trials of an AstraZeneca cancer drug have indicated the potential for “combination therapies” to widen the range...

  28. February 4, 2016

    Numbers games and existential angst

    Two down-at-heel figures loitered in a desolate landscape. It could have been Waiting for Godot, a play by Irish...

  29. February 4, 2016

    AstraZeneca warns of lower earnings ahead of patent losses

    AstraZeneca has urged investors to keep focused on long-term growth after its shares were sent tumbling by a warning of...

  30. Fast FT

    February 4, 2016

    AstraZeneca shares hit as 2016 revenue forecast to fall

    AstraZeneca’s chief executive Pascal Soriot may be reassured that the UK drugmaker is on the right path but...

  31. Fast FT

    February 4, 2016

    Opening Quote: Shell protects divi, Compass ploughs on

    Shell’s profits have slumped with the oil price, AstraZeneca’s sales are stalling, the Bank of England is set to hold...

  32. FT Alphaville

    February 4, 2016

    FT Opening Quote

    Shell profits have slumped with the oil price, AstraZeneca sales are stalling, the Bank of England is set to hold...

  33. Fast FT

    February 4, 2016

    AstraZeneca warns of revenue, earnings drop this year

    AstraZeneca has cautioned shareholders that revenue and earnings per share this year will decline by a “low to mid...

  34. Fast FT

    February 3, 2016

    Opening Quote: Hargreaves shrugs off difficult markets

    Hargreaves Lansdown’s assets under management have risen to a record despite difficult markets for investors,...

  35. FT Alphaville

    February 3, 2016

    FT Opening Quote

    Hargreaves Lansdown’s assets under management have risen to a record despite difficult markets for investors, ChemChina...

  36. Fast FT

    February 1, 2016

    Opening Quote: Smith & Nephew, BT, EU/sardines

    Smith & Nephew says its CEO has a “highly treatable” form of cancer, BT is reshaping itself following its EE...

  37. January 31, 2016

    Gilead risks becoming victim of its own success

    During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

  38. Fast FT

    January 28, 2016

    Opening Quote: Babcock's CEO retires

    Diageo is upbeat, despite a writedown for its Brazilian liquor business, Babcock’s CEO is retiring, Jimmy Choo shoe...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the drugmaker's discussions with Acerta Pharma...
    December 14, 2015

    Lex on the drugmaker's discussions with Acerta Pharma

  2. Lex on the pharma group’s drug pipeline...
    September 4, 2015

    Lex on the pharma group’s drug pipeline

  3. British pharma group accuses UK of stymieing progress...
    June 2, 2015

    British pharma group accuses UK of stymieing progress